The Indian government's Product Linked Incentive (PLI) scheme has led to a significant increase in the local production of high-end medical devices, including MRI machines and heart valves.
This development is crucial for India as it reduces the country's reliance on imported medical devices, thereby improving healthcare accessibility and affordability for its citizens.
Key Takeaways
- The PLI scheme has led to a significant increase in the local production of high-end medical devices in India.
- The scheme has attracted leading global manufacturers, encouraging technology transfer and advanced manufacturing capabilities in India.
- The increased local production of medical devices is expected to improve healthcare outcomes, reduce costs, and enhance the overall quality of medical care in India.
What happened
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, announced that the production of 57 medical devices has commenced under the PLI scheme, which were earlier predominantly imported.
These devices include MRI machines, CT scanners, Cath Labs, Linear Accelerators, C-Arms, mammography machines, ultrasound systems, anaesthesia machines, and heart valves.
Why it matters
The PLI scheme has attracted leading global manufacturers such as GE Healthcare, Siemens, Philips, Varex, Nipro, and Omron, encouraging technology transfer and advanced manufacturing capabilities in India.
This initiative has the potential to transform India's healthcare landscape by providing access to high-quality medical devices, creating jobs, and stimulating economic growth.
What it means for you
The increased local production of medical devices is expected to improve healthcare outcomes, reduce costs, and enhance the overall quality of medical care in India.
Patients will have access to a wider range of medical devices, and healthcare providers will be able to offer more effective treatments, leading to better health outcomes.
By the numbers
- Rs 3,420 crore: The total financial outlay of the PLI scheme.
- 5 per cent: The incentive provided on incremental sales of eligible medical devices manufactured in India for a period of five years.
- 57: The number of medical devices whose production has commenced under the PLI scheme.
- 2020: The year the PLI scheme was launched.
What happens next
The Indian government is expected to continue supporting the growth of the medical device industry through initiatives like the PLI scheme, which will help to establish India as a hub for medical device manufacturing.
As the industry continues to evolve, we can expect to see more innovative medical devices being produced in India, leading to improved healthcare outcomes and a stronger economy.
The PLI scheme covers four broad segments: cancer care/radiotherapy medical devices, radiology and imaging devices, anaesthesia, cardio-respiratory and renal care devices, and implants, including implantable electronic devices.
The scheme's focus on these segments will help address the country's healthcare needs and provide opportunities for domestic manufacturers to produce high-quality medical devices.
Furthermore, the scheme's emphasis on technology transfer and advanced manufacturing capabilities will enable Indian manufacturers to develop cutting-edge medical devices, enhancing the country's competitiveness in the global market.
In the long term, the PLI scheme is expected to have a positive impact on India's healthcare sector, leading to improved health outcomes, increased accessibility, and affordability of medical devices.
The scheme will also contribute to the growth of the Indian economy, creating new job opportunities and stimulating innovation in the medical device industry.
Additionally, the PLI scheme will help reduce India's dependence on imported medical devices, which will lead to a significant reduction in the country's trade deficit.
With the growth of the medical device industry, India can also expect to see an increase in foreign investment, as global companies look to tap into the country's growing healthcare market.
The Indian government's initiative to promote the growth of the medical device industry is a step in the right direction, and it is expected to have a positive impact on the country's healthcare sector and economy in the long run.
Frequently Asked Questions
What is the PLI scheme?
The Product Linked Incentive (PLI) scheme is an initiative launched by the Indian government to promote the growth of the medical device industry in India.
What are the benefits of the PLI scheme?
The PLI scheme provides a 5 per cent incentive on incremental sales of eligible medical devices manufactured in India for a period of five years, and it covers four broad segments of medical devices.
How will the PLI scheme impact India's healthcare sector?
The PLI scheme is expected to have a positive impact on India's healthcare sector, leading to improved health outcomes, increased accessibility, and affordability of medical devices.
